Literature DB >> 16951824

[Carotid intimal-medial thickening and endothelial function in coronary artery disease].

Graziela Chequer1, Bruno Ramos Nascimento, Túlio Pinho Navarro, Eduardo Belisário Falqueto, Maria Clara N Alencar, Márcio Cristiano R de Miranda, Ari Mandil, Jamil Abdalla Saad, Cirilo Fonseca, Antônio Luiz Pinho Ribeiro.   

Abstract

OBJECTIVE: To investigate the correlation between the endothelial function and the carotid intimal-medial thickening (IMT) in a population of patients with coronary artery disease, as well as that between the endothelial function and carotid IMT with the severity of the coronary lesions.
METHODS: Forty-three patients aged 60.5+/-9.2 years, (67.4% males) with coronary artery disease at the coronariography were studied. Endothelial function was assessed using the brachial artery reactivity test (BART), which measured the percentage of flow-mediated dilatation (%FMD). The carotid IMT was evaluated through vascular ultrasound.
RESULTS: The mean %FDM was 4.7 +/- 3.6 and the mean carotid IMT was 1.08 +/- 0.23 mm. The carotid MIT and %FMD measurements showed a statistically significant correlation, with Spearmans coefficient of 0.315, p= 0.042, demonstrating that lower %FMD values corresponded to an increased carotid IMT (r = -0.315, p = 0.042). There was no correlation between %FMD or IMT and the severity of coronary lesions.
CONCLUSIONS: The presence of a correlation between carotid IMT and %FMD demonstrates a concomitance of anatomical and functional vascular alterations in coronary artery disease, regardless of the severity of the atherosclerotic lesions.

Entities:  

Mesh:

Year:  2006        PMID: 16951824     DOI: 10.1590/s0066-782x2006001500004

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  1 in total

Review 1.  Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier.

Authors:  Aline Cristina Tavares; Edimar Alcides Bocchi; Guilherme Veiga Guimarães
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.